This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Updated report on trends in global PD-1/PD-L1 immunotherapy clinical development from the Cancer Research Institute published in Nature Reviews Drug Discovery.
Cancer Research Institute leverages data from GlobalData’s Pharma Intelligence platform in an immuno-oncology landscape update.
Latest immuno-oncology landscape report from the Cancer Research Institute published in Nature Reviews Drug Discovery highlights increasing global expansion and innovation.
The Cancer Research Institute and AER Technologies have partnered to raise vitals funds for the advancement of cancer immunotherapy research.
Cancer Research Institute announces 2019 recipients of its top scientific and philanthropic awards honoring discovery, service in advancing cancer immunology and immunotherapy research.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with advanced cervical cancer.
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.